Brukinsa Európska únia - islandčina - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Æxlishemjandi lyf - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Gavreto Európska únia - islandčina - EMA (European Medicines Agency)

gavreto

roche registration gmbh  - pralsetinib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - gavreto is indicated as monotherapy for the treatment of adult patients with rearranged during transfection (ret) fusion-positive advanced non-small cell lung cancer (nsclc) not previously treated with a ret inhibitor.

Lumykras Európska únia - islandčina - EMA (European Medicines Agency)

lumykras

amgen europe bv - sotorasib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Regiocit (Prismocit) Blóðsíunarlausn 18/140 mmól/l Island - islandčina - LYFJASTOFNUN (Icelandic Medicines Agency)

regiocit (prismocit) blóðsíunarlausn 18/140 mmól/l

baxter holding b.v.* - sodium citrate; sodium chloride - blóðsíunarlausn - 18/140 mmól/l

Biphozyl (Calfodil) Blóðskilunar-/blóðsíunarlausn 22 mmól/l Island - islandčina - LYFJASTOFNUN (Icelandic Medicines Agency)

biphozyl (calfodil) blóðskilunar-/blóðsíunarlausn 22 mmól/l

baxter holding b.v.* - magnesii chloridum; natrii chloridum; sodium hydrogen carbonate; kalii chloridum; dinatrii hydrogenophosphas - blóðskilunar-/blóðsíunarlausn - 22 mmól/l

Sativex Munnholsúði, lausn 27 mg/ml + 25 mg/ml Island - islandčina - LYFJASTOFNUN (Icelandic Medicines Agency)

sativex munnholsúði, lausn 27 mg/ml + 25 mg/ml

jazz pharmaceuticals ireland ltd - delta-9-tetrahydrocannabinolum; cannabidiolum inn - munnholsúði, lausn - 27 mg/ml + 25 mg/ml